Navigation Links
Mentice Appoints Bjorn Larsson as Vice President of Global Marketing
Date:10/13/2008

GOTHENBURG, Sweden, October 13 /PRNewswire/ -- Mentice, a leading supplier of solutions for medical simulation, announces the appointment of Mr. Bjorn Larsson as Vice President of Global Marketing.

Effective from today Mr. Bjorn Larsson will head up and coordinate Mentice's marketing activities globally from a corporate standpoint.

Mr. Larsson brings to Mentice over 15 years of experience of global sales, marketing and product management within pharmaceuticals and medical technology in areas including cardiology, stroke management and CNS. Before joining Mentice, he held global leadership positions at well renowned companies like Astra Zeneca, Novo Nordisk, Medtronic and Astra Tech. Mr. Larsson holds an MSc in Mechanical Engineering.

"Medical simulation is today widely endorsed for enhancing skills, improving clinical outcome and patient safety" says Mr Bjorn Larsson, Vice President of Global Marketing. He continues: "Mentice is uniquely positioned to further strengthen its leadership in this field. We are determined to provide the most innovative medical simulation solutions as an integral part of physician training and education."

"Bjorn's extensive background in the pharmaceutical and med-tech areas will clearly be a great contribution to our organisation and will help to strengthen our position in the global market place." says Goran Malmberg, President/CEO of Mentice.

Mentice - Improving Patient Safety

Mentice is a world leader in medical simulation, providing qualified solutions for training, education and assessment of medical professionals. With a focus on minimally invasive techniques and procedures, Mentice develops simulation systems for training in a virtual environment within the fields of endovascular intervention and endoscopic surgery. Mentice's solutions have documented effects of improving participants' learning, reducing costs, enhancing training effectiveness and eventually, improving patient safety.

For further information, please contact Goran Malmberg, President/CEO of Mentice, Phone: +46-31-33-99-401.


'/>"/>
SOURCE Mentice AB
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Mentice AB Announces Leadership Changes Within Its Worldwide Operations
2. Mentice AB Announces the Appointment of Lars Lonn as Clinical Director for Mentice
3. Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation
4. Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership
5. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
6. Codexis Appoints Singapore Laboratories Managing Director
7. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
8. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
11. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), ... , today announced that its board of directors has amended its ... from March 27, 2017 to March 27, 2018. The amendment was not ... Biotech Ltd. ... Sinovac Biotech Ltd. is a China -based ...
(Date:3/24/2017)... -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with ... today announced participation at the following conferences: ... Maidstone Life Sciences conference "Cancer Immunotherapy Conference" at the ... York, NY . Agenus will participate in three ... Robert B. Stein , M.D., Ph.D., President, R&D ...
(Date:3/23/2017)... Research and Markets has announced the addition of the ... ... The Global Market for Bioproducts Should Reach $714.6 Billion by ... 8.9%, This research report quantifies the two ... segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and herbal/botanicals), biocomposite materials, ...
(Date:3/23/2017)... LOUISVILLE, Colo. , March 23, 2017  GlobeImmune, ... purchase agreement for the sale of 12,835,490 shares of ... the  NantWorks  ecosystem of companies. In connection with the sale ... GlobeImmune $100,000 in cash and issue to GlobeImmune 200,000 ... common stock. "We are pleased to ...
Breaking Biology Technology:
(Date:3/16/2017)... 2017 - Against identity fraud with DERMALOG solutions "Made in Germany "  ... ... project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution against ... ...
(Date:3/7/2017)... March 7, 2017 Brandwatch , the leading social ... The Prince,s Trust to uncover insights to support its reporting, ... The UK,s leading youth charity will be using Brandwatch ... and get a better understanding of the topics and issues that ... ...
(Date:3/2/2017)... 2017 Summary This report provides ... KGaA and its partnering interests and activities since 2010. ... Description The Partnering Deals and Alliance since 2010 report ... one of the world,s leading life sciences companies. ... to ensure inclusion of the most up to date ...
Breaking Biology News(10 mins):